Device Trial Radar · NCT07468617
Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Jan 2, 2027
Primary completion
Apr 1, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- CSA Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 12, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being conducted to determine the safety of repeat metered cryospray (MCS) treatment in patients with COPD with chronic bronchitis previously treated with MCS.
Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
- Chronic Bronchitis
Interventions
Metered cryospray (MCS)Device
Bronchial metered cryospray (MCS)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Completed MCS treatment applicationsTime frame: Treatment 1 and Treatment 2
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.